1. 1379TiPPhase I/II study of S 49076, a MET/AXL/FGFR inhibitor, in combination with gefitinib in EGFR-mutated NSCLC patients who progress on EGFR tyrosine kinase inhibitor. (18th September 2017) Authors: Park, K.; Ciardiello, F.; Hida, T.; Lim, W.; Lin, C-C.; Murakami, H.; Nishio, M.; Cantero, F.; Cattan, V.; Gabarroca, C.; Gandossi, E.; Paz-Ares, L. Journal: Annals of oncology Issue: Volume 28(2017)Supplement 5 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. 3068 Impact of total lesion glycolysis at pretreatment FDG PET/CT on response duration of EGFR-TKIs in advanced NSCLC harboring EGFR mutation. (September 2015) Authors: Yoshida, T.; Oya, Y.; Tanaka, K.; Shimizu, J.; Horio, Y.; Hida, T.; Yatabe, Y. Journal: European journal of cancer Issue: Volume 51:(2015)Supplement 3 Page Start: S619 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. 3069 Impact of alectinib on survival after crizotinib failure in ALK-positive NSCLC patients. (September 2015) Authors: Yoshida, T.; Oya, Y.; Tanaka, K.; Junichi, S.; Yoshitsugu, H.; Hida, T.; Yatabe, Y. Journal: European journal of cancer Issue: Volume 51:(2015)Supplement 3 Page Start: S619 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. 473PDriver oncogene status in early-emerging lung adenocarcinoma. (19th December 2015) Authors: Tanaka, K.; Oya, Y.; Yoshida, T.; Shimizu, J.; Horio, Y.; Hida, T.; Yatabe, Y. Journal: Annals of oncology Issue: Volume 26(2015)Supplement 9 Page Start: ix144 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. 521 Phase II studies of Nivolumab in patients with Advanced Squamous (SQ) or Non-Squamous (NSQ) Non-Small Cell Lung Cancer (NSCLC). (September 2015) Authors: Sakai, H.; Nishio, M.; Hida, T.; Nakagawa, K.; Nogami, N.; Atagi, S.; Takahashi, T.; Nokihara, H.; Saka, H.; Takenoyama, M.; Fujita, S.; Tanaka, H.; Takeda, K.; Satouchi, M.; Isobe, H.; Maemondo, M.; Goto, K.; Hirashima, T.; Minato, K.; Tamura, T. Journal: European journal of cancer Issue: Volume 51:(2015)Supplement 3 Page Start: S110 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. A case of childhood‐onset cutaneous mastocytosis with loss of wild‐type KIT allele. (11th March 2019) Authors: Hida, T.; Okura, M.; Kamiya, T.; Yamamoto, M.; Hori, T.; Uhara, H. Journal: Journal of the European Academy of Dermatology and Venereology Issue: Volume 33:Number 6(2019) Page Start: e235 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. A case of subepidermal autoimmune bullous disease with autoantibodies against 200 and 290‐kDa antigens. (26th March 2018) Authors: Sawada, M.; Hida, T.; Ujiie, H.; Iwata, H.; Uhara, H. Journal: Journal of the European Academy of Dermatology and Venereology Issue: Volume 32:Number 9(2018) Page Start: e354 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. Detectability of hepatocellular carcinoma on gadoxetic acid-enhanced MRI at 3 T in patients with severe liver dysfunction: clinical impact of dual-source parallel radiofrequency excitation. Issue 3 (March 2015) Authors: Nishie, A.; Kakihara, D.; Asayama, Y.; Ushijima, Y.; Takayama, Y.; Fujita, N.; Shimamoto, D.; Shirabe, K.; Hida, T.; Honda, H. Journal: Clinical radiology Issue: Volume 70:Issue 3(2015) Page Start: 254 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. Development of on-chip pattern processing in event-driven SOI pixel detector for X-ray astronomy with background rejection purpose. (1st December 2020) Authors: Takeda, A.; Mori, K.; Nishioka, Y.; Hida, T.; Yukumoto, M.; Kanemaru, Y.; Yonemura, S.; Mieda, K.; Tsuru, T. G.; Tanaka, T.; Kurachi, I.; Arai, Y. Journal: Journal of instrumentation Issue: Volume 15:Number 12(2020) Page Start: P12025 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
10. Granulocyte colony‐stimulating factor‐producing melanoma treated with the combination of dabrafenib and trametinib. (14th April 2018) Authors: Minowa, T.; Kato, J.; Hida, T.; Horimoto, K.; Sato, S.; Sawada, M.; Takahashi, H.; Uhara, H. Journal: International journal of dermatology Issue: Volume 57:Number 7(2018) Page Start: e31 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗